Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Inhaled Interferon α2b Treatment in Mild-to-moderate COVID-19 Infected Children

NCT05381363 is registered in ClinicalTrials.gov with Children's Hospital of Fudan University as lead sponsor.

NCT NCT05381363
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05381363 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Inhaled Interferon α2b Treatment in Mild-to-moderate COVID-19 Infected Children
Lead sponsor
Children's Hospital of Fudan University
Phase
Phase 1/2
Overall status
Terminated
Start date
January 1, 2022
Completion date
January 1, 2023
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

children, covid-19